Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $0 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 43.2% | 107.2% | -54.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 33.3% | 100% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 63% | 54.7% | -24.5% | 36.9% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 32.8% | 27.7% | -90.9% | 2.5% |
| EPS Diluted | 0.23 | 0.14 | -0.23 | 0.014 |
| % Growth | 64.3% | 160.9% | -1,731.2% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |